Case Information
*1
A D Bedell Wholesale v. Philip Morris Inc
Precedential or Non-Precedential: Docket 00-3410
Follow this and additional works at: http://digitalcommons.law.villanova.edu/thirdcircuit_2001
Recommended Citation
"A D Bedell Wholesale v. Philip Morris Inc" (2001). 2001 Decisions. Paper 133. http://digitalcommons.law.villanova.edu/thirdcircuit_2001/133
This decision is brought to you for free and open access by the Opinions of the United States Court of Appeals for the Third Circuit at Villanova University School of Law Digital Repository. It has been accepted for inclusion in 2001 Decisions by an authorized administrator of Villanova University School of Law Digital Repository. For more information, please contact Benjamin.Carlson@law.villanova.edu.
*2 UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT
No. 00-3410
A.D. BEDELL WHOLESALE COMPANY, INC.; TRIANGLE CANDY & TOBACCO CO., on behalf of themselves and all others similarly situated, Appellants
v.
PHILIP MORRIS INCORPORATED; R.J. REYNOLDS TOBACCO COMPANY, INC.; BROWN AND WILLIAMSON TOBACCO CORP.
On Appeal from the United States District Court for the Western District of Pennsylvania D.C. Civil Action No. 99-cv-00558 (Honorable Donetta W. Ambrose)
Argued December 14, 2000
Before: SCIRICA, FUENTES and GARTH, Circuit Judges (Filed: June 19, 2001)
*3 DAVID F. DOBBINS, ESQUIRE (ARGUED) Patterson, Belknap, Webb &; Tyler 1133 Avenue of the Americas New York, New York 10036 WILLIAM M. WYCOFF, ESQUIRE Thorp, Reed &; Armstrong One Oxford Centre 301 Grant Street Pittsburgh, Pennsylvania 15219 ALAN R. WENTZEL, ESQUIRE Windels, Marx, Lane &; Mittendorf 156 West 56th Street New York, New York 10019 Attorneys for Appellants DOUGLAS L. WALD, ESQUIRE (ARGUED) Arnold &; Porter 555 12th Street, N.W. Washington, D.C. 20004 BERNARD D. MARCUS, ESQUIRE Marcus &; Shapira One Oxford Centre, 35th Floor 301 Grant Street Pittsburgh, Pennsylvania 15219 Attorneys for Appellee, Philip Morris Incorporated
*4
GREGORY G. KATSAS, ESQUIRE (ARGUED)
Jones, Day, Reavis & Pogue
51 Louisiana Avenue, N.W.
Washington, D.C. 20001
JOHN E. IOLE, ESQUIRE
Jones, Day, Reavis & Pogue
500 Grant Street, 31st Floor
Pittsburgh, Pennsylvania 15219
Attorneys for Appellee,
R.J. Reynolds Tobacco Company, Inc.
TIMOTHY P. RYAN, ESQUIRE
Eckert, Seamans, Cherin & Mellott
600 Grant Street, 44th Floor
Pittsburgh, Pennsylvania 15219
Attorney for Appellee,
Brown and Williamson Tobacco Corp.
ERIK S. JAFFE, ESQUIRE (ARGUED)
5101 34th Street, N.W.
Washington, D.C. 20008
THOMAS C. O'BRIEN, ESQUIRE
36 West 5th Street
Corning, New York 14830
Attorneys for Amici Curiae-Appellants,
The Cato Institute, The Competitive Enterprise Institute,
and The National Smokers Alliance
*5 JOEL M. RESSLER, ESQUIRE Office of Attorney General of Pennsylvania Strawberry Square, 15th Floor Harrisburg, Pennsylvania 17120 Attorney for Amici Curiae-Appellees, Attorneys General of Pennsylvania, California, Alaska, American Samoa, Arizona, Arkansas, Colorado, Connecticut, Delaware, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, and Wyoming
OPINION OF THE COURT
SCIRICA, Circuit Judge. This is an appeal from the dismissal under Fed. R. Civ. P. 12(b)(6) of claims brought under the Sherman Antitrust Act attacking the multi-billion dollar national tobacco settlement. Endeavoring to recoup billions of dollars in public health care costs and to reduce cigarette smoking, several states brought suit against the leading United States tobacco manufacturers. In view of the magnitude of potential liability and the prospect of multiple actions, the parties asked Congress to resolve the suits through a national legislative remedy. After congressional efforts stalled, fortysix states forged a settlement with the tobacco manufacturers known as the Multistate Settlement Agreement. Plaintiffs, who are cigarette wholesalers, challenge the Multistate Settlement Agreement as a violation of and of the Sherman Antitrust Act. The District Court held that plaintiffs failed to state a claim under the Sherman Act because the tobacco companies were immune from antitrust liability under both the Noerr-Pennington and Parker immunity doctrines. We agree they are immune under the Noerr-Pennington doctrine but not under the Parker doctrine. We will affirm.
*6
I.
Facts and Procedural History A.D. Bedell, a cigarette wholesaler, brought this class action on behalf of itself and 900 similarly situated wholesalers seeking damages and a permanent injunction of the Multistate Settlement Agreement. Defendants, Philip Morris, Inc., R.J. Reynolds
Tobacco Co., Inc., and Brown &; Williamson Tobacco Corp., are cigarette manufacturers who were original signatories to the Multistate Settlement Agreement. Along with Lorillard Tobacco Co., the fourth largest cigarette producer, they are collectively known as the major tobacco companies or the Majors. The Majors are responsible for of cigarette sales in the United States. Bedell, as a wholesaler, bought directly from the Majors. In the mid 1990's, individual states commenced bringing law suits against the Majors to recoup healthcare costs and reduce smoking by minors. As one state Attorney General declared, "‘[The] lawsuit is premised on a simple notion: you caused the health crisis; you pay for it.'" Janofsky, Mississippi Seeks Damages from Tobacco Companies, N.Y. Times, May 24, 1994, at A12 (quoting Mississippi Attorney General Mike Moore). The States alleged a wide range of deceptive and fraudulent practices by the tobacco companies over decades of sales. Faced with the prospect of defending multiple actions nationwide, the Majors sought a congressional remedy, primarily in the form of a national legislative settlement. In June 1997, the National Association of Attorneys General and the Majors jointly petitioned Congress for a global resolution.
The proposed congressional remedy (1997 National Settlement Proposal) for the cigarette tobacco problem resembled the eventual Multistate Settlement Agreement, but with important differences. For example, although the congressional proposal would have earmarked of all funds to combat teenage smoking, no such restrictions appear in the Multistate Settlement Agreement. 1997 National Settlement Proposal, Title VII, available at http://www.cnn.com/us/9705/tobacco/docs/proposal.html (last visited June 18, 2001). In addition, the congressional proposal would have mandated Food &; Drug
*7 Administration oversight and imposed federal advertising restrictions. It also would have granted immunity from state prosecutions; eliminated punitive damages in individual tort suits; and prohibited the use of class actions, or other joinder or aggregation devices without the defendant's consent, assuring that only individual actions could be brought. See id. at Title V(A), VIII(A), VIII(B). The congressional proposal called for payments to the States of billion over twentyfive years. 1997 National Settlement Proposal, Title VI. By contrast, assuming that the Majors would maintain their market share, the Multistate Settlement Agreement provides baseline payments of about billion over twenty-five years. See Multistate Settlement Agreement, , (b), (c). Significantly for our purposes, the congressional proposal included an explicit exemption from the federal antitrust laws. See 1997 National Settlement Proposal, App. IV(C)(2) (stating cigarette manufacturers would have been permitted to "jointly confer, coordinate or act in concert, for this limited purpose [of achieving the goals of the settlement]"). The Multistate Settlement Agreement contains no corresponding exemption from the federal antitrust laws. Congress rejected the proposed settlement in the spring of 1998. Undeterred, the State Attorneys General and the Majors continued to negotiate and on November 23, 1998, they executed the Multistate Settlement Agreement. Afterwards, twenty other tobacco manufacturers, representing 2\% of the market, joined the settlement as Subsequent Participating Manufacturers (SPMs). The addition of the Subsequent Participating Manufacturers meant that nearly all of the cigarette producers in the domestic market had signed the Multistate Settlement Agreement. Their addition was significant. The Majors allegedly feared that any cigarette manufacturer left out of a settlement (Non-Participating Manufacturers or NPMs) would be free to expand market share or could enter the market with lower prices, drastically altering the Majors' future profits and their ability to increase prices to pay for the settlement. Plaintiffs brought suit challenging sections of the Multistate Settlement
*8 Agreement allegedly designed to maintain market share and restrict entry. The challenged sections of the Multistate Settlement Agreement are the socalled "Renegade Clause," the settlement's primary mechanism for allocating payment responsibilities based on production levels, and the provision calling for "Qualifying Statutes," which are state laws passed as a result of commitments made in the Multistate Settlement Agreement that require Non-Participating Manufacturers to pay into state escrow accounts for each sale made. Plaintiffs claim the Multistate Settlement Agreement and resulting state implementing statutes create an output cartel that imposes draconian monetary penalties for increasing cigarette production beyond 1998 levels and effectively bars new entry into the cigarette market. The Renegade Clause allegedly was designed to prevent current cigarette manufacturers from decreasing prices to increase market share and to bar new entrants from the market. One part of the Renegade Clause affects tobacco companies (SPMs) that later join the Multistate Settlement Agreement. This section creates strong disincentives for Subsequent Participating Manufacturers to increase their production and market share. If a Subsequent Participating Manufacturer exceeds its 1998 market share (or exceeds of 1997 market share if that is greater), then it must pay into the settlement fund. By maintaining historic market share, it would owe nothing to the settlement fund. For every carton of cigarettes sold in 1999 over its 1998 level, a SPM would have to pay $.19/pack into the settlement fund. Plaintiffs contend this equaled of the wholesale price, which defendants do not contest. See Br. of Appellants at 14 (applying MSA IX(C)); MSA Ex. E. This mechanism allegedly discourages Subsequent Participating Manufacturers from underpricing the Majors to increase market share, even if they could efficiently do so. Another part of the Renegade Clause affects Non-Participating Manufacturers (NPMs), cigarette companies that never sign the Multistate Settlement Agreement. Non- Participating Manufacturers include potential new entrants into the tobacco market. See MSA . But as noted, between the SPMs and the Majors, about of the current
*9 cigarette producers signed the Multistate Settlement Agreement. The strictures of the Multistate Settlement Agreement affecting NPMs were largely responsible for such participation. Potential new entrants into the cigarette market would bear the burden of the Renegade Clause's future effects. Under the Renegade Clause, if Non-Participating Manufacturers gain market share (thereby reducing the Majors' market share) the Majors may decrease their principal payments to the settlement fund. If the Majors lose market share to NPMs, the payments to the settlement fund are not merely reduced proportionately. See MSA IX(d)(1)(A) &; (B). For example, if a participating tobacco company lost of its market share to a new entrant or other company that did not sign the Multistate Settlement Agreement, it may be able to reduce its payments by as much as . See Hanoch Dagan &; James J. White, Governments, Citizens, and Injurious Industries, 75 N.Y.U. L. Rev. 354, 381 (2000) (making hypothetical calculations based on the formulas in MSA .
By enacting the Qualifying Statute set forth in the Multistate Settlement Agreement, see MSA Ex. T, a state can preclude reduced payments. The model statute provides,
*10 Any tobacco product manufacturer selling cigarettes to consumers within the State . . . after the date of enactment of this Act shall do one of following: (a) become a participating manufacturer (as that term is defined in section II(jj) of the Master Settlement Agreement) and generally perform its financial obligations under the Master Settlement Agreement; or (b) (1) place into a qualified escrow fund . . . the following amounts Id.
The model Qualifying Statute would impose a tax on new tobacco entrants of approximately pack in the year 2001, rising to pack by the year 2007. See
MSA Ex. T. A Non-Participating Manufacturer only can recover its deposited funds: (1) if it is forced to pay a judgment or settlement in connection with a claim brought by the state, or (2) after the passage of twenty years free from any such judgments. See id. Because the Non-Participating Manufacturers are not part of the settlement, they have no immunity and would be subject to similar suits brought by the State Attorneys General against the Majors (for fraudulent concealment, misrepresentation, conspiracy, etc.). To encourage and assist the States in bringing these suits, the Multistate Settlement Agreement created a million Enforcement Fund (paid for by the Majors) to investigate and sue NPMs to enforce the settlement. See MSA VIII(c). Because of the Qualifying Statutes, a Non-Participating Manufacturer must decide either to join the Multistate Settlement Agreement and abide by the same restrictions on market share facing a SPM (which for new manufacturers would be costly because they would have a baseline production level of zero), or face litigation and pay a tax into a state established escrow account for any potential adverse judgments. Together, the Renegade Clause, the Qualifying Statutes and the Enforcement Fund allegedly create severe obstacles to market entry, or to increasing production and market share. This is not accidental. The Multistate Settlement Agreement explicitly
*11
proclaims its purpose to reduce the ability of non-signatory cigarette manufacturers to seize market share because of the competitive advantage accruing from not contributing to the settlement. It declares that the agreement "effectively and fully neutralizes the cost disadvantages that the Participating Manufacturers experience vis-a-vis Non- Participating Manufacturers with such Settling States as a result of the provisions of this Agreement." MSA . It is these barriers to entry and increased production that plaintiffs claim form an output cartel that violates the antitrust laws. Because output is restricted and because of the inelastic demand for cigarettes, in part due to their addictive nature, the Multistate Settlement Agreement allegedly permitted the Majors to raise their prices to near monopoly levels levels allegedly above those necessary to fund the settlement payments. For example, assert plaintiffs, the settlement could have been funded by only a $.19/pack increase in price, but the Majors immediately raised prices by $.45/pack, and subsequently by another $.31/pack. When this lawsuit was filed, the Majors had already raised the wholesale price of cigarettes $.76/pack since the adoption of the Multistate Settlement Agreement. Rapid price increases of this magnitude would ordinarily permit competitors to maintain or reduce prices or prompt new competitors to enter the market. But neither occurred, assert plaintiffs, because the barriers erected by the Multistate Settlement Agreement effectively barred entry and discouraged tobacco companies from maintaining a lower price because of the penalties for increased production. Defendants contend the Multistate Settlement Agreement did not violate the antitrust laws, but even if so, they are immune under both the NoerrPennington doctrine, which protects petitioning activity, and the Parker doctrine, which protects sovereign acts of states from antitrust liability. We turn first to the antitrust issues.
II.
Antitrust Injury The defendants argue the express terms of the Multistate Settlement Agreement do not constitute an agreement to limit output in violation of the antitrust laws. Plaintiffs
*12
counter that the Multistate Settlement Agreement's Renegade Clause, Qualifying
Statutes, and Enforcement Fund, have the "unequivocal purpose and effect" to
"effectuate a cartel limiting the output of cigarettes, thereby allowing the Majors to
maintain supracompetitive prices," which is a per se violation of the antitrust laws. Br.
of Appellants at 29 .
To maintain a cause of action under the Sherman Act, "[p]laintiffs must prove
antitrust injury, which is to say (1) injury of the type the antitrust laws were intended to
prevent and (2) that flows from that which makes defendants' acts unlawful." Brunswick
Corp. v. Pueblo Bowl-O-Mat,
*13
An agreement which has the purpose and effect of reducing output is illegal under
of the Sherman Act. Cal. Dental Ass'n v. FTC,
The Court cited with approval a case from the Court of Appeals of the Seventh Circuit
which held that if "'firms restrict output directly, price will rise in order to limit demand
to the reduced supply. Thus, with exceptions not relevant here, raising price, reducing
output, and dividing markets have the same anticompetitive effects.'" Id. at 777 (quoting
General Leaseways, Inc. v. Nat'l Truck Leasing Ass'n,
*14
agreements" and violators are prosecuted criminally without regard to "claimed business
purposes, anticompetitive harms, procompetitive benefits, or overall competitive effects."
Id.
Plaintiffs allege the agreement between the States and the Majors purposefully creates powerful disincentives to increase cigarette production. Although the Multistate Settlement Agreement contains no explicit agreement to raise prices or restrict market
share, any signatory who increases production beyond historic levels automatically will
increase its proportionate share of payments to the Multistate Settlement Agreement.
Normally, a company which lowers prices would be expected to increase market share.
But the penalty of higher settlement payments for increased market share would
discourage reducing prices here. For this reason, signatories have an incentive to raise
prices to match increases by competitors. It appears this incentive structure has proven
true. The Majors' prices increased dramatically and simultaneously after signing the
Multistate Settlement Agreement. As noted, this included a $.45/pack increase just days
after the settlement was announced, an $.18/pack increase less than a year later, and a
$.13/pack increase in January of 2000. The initial $.45 increase alone was more than
double what some analysts considered necessary to fund the settlement's first two annual
payments. See Stuart Taylor Jr., All for Tobacco and Tobacco for All, 23 Legal Times
40, Oct. 9, 2000.
Defendants contend an antitrust analysis is unnecessary if we find either Noerr-
Pennington or Parker immunity applies. But plaintiffs argue that immunity cannot attach
to per se antitrust violations. We disagree. Recently we recognized immunity attached
even where the plaintiff alleged a boycott regarded as illegal per se. Armstrong Surgical
Ctr. Inc., v. Armstrong Mem'l Hosp.,
*15
v. Pennington,
Our review at this stage is limited to the allegations in plaintiffs' complaint. On a motion to dismiss under Fed. R. Civ. P. 12(b)(6), the issue is whether plaintiffs have properly pleaded an antitrust violation. Plaintiffs allege that defendants formed an output cartel through the Multistate Settlement Agreement that restricts production and effectively bars entry to the cigarette tobacco market. Plaintiffs also allege the cartel injured the tobacco wholesalers by charging artificially high prices. We hold that plaintiffs have properly pleaded an antitrust violation by alleging defendants agreed to form an output cartel through the Multistate Settlement Agreement that violates and of the Sherman Antitrust Act. But we will affirm if the parties to the Multistate Settlement Agreement are immune under the NoerrPennington or the Parker doctrines. We turn now to that question. III.
Antitrust Immunity
Defendants contend they are immune from antitrust liability under both the Noerr-
Pennington doctrine, which immunizes parties involved in petitioning the government,
and under the Parker doctrine, which immunizes sovereign state action. Although
distinct doctrines, there is substantial overlap as both "work at the intersection of
antitrust and governance." The two doctrines share a fundamental similarity. The
Supreme Court has stated they are "complementary expressions of the principle that the
antitrust laws regulate business, not politics; Parker protects the States' acts of
governing, and Noerr the citizens' participation in government." City of Columbia v.
Omni Outdoor Adver. Inc.,
Under the Noerr-Pennington doctrine, "[a] party who petitions the government for
redress generally is immune from antitrust liability." Cheminor Drugs, Ltd. v. Ethyl
Corp.,
*16
Presidents Conference v. Noerr Motor Freight, Inc.,
*17 enacted to regulate private business and do not abrogate the right to petition.
The scope of Noerr-Pennington immunity, however, depends on the "source, context, and nature of the competitive restraint at issue." Allied Tube &; Conduit Corp.
v. Indian Head, Inc.,
*18 District Court held defendants immune under Noerr-Pennington. Specifically, it held that the "concerted effort by defendants to influence public officials, i.e., the states'
Attorneys General, to accept a settlement in exchange for dismissing the numerous
lawsuits pending against defendants is among the activities protected by the Noerr-
Pennington doctrine." A.D. Bedell,
The importance of the right to petition has been long recognized. As early as
1215, the Magna Carta granted barons the right to petition the King of England for
redress. See Julie M. Spanbauer, The First Amendment Right to Petition Government
for a Redress of Grievances: Cut From a Different Cloth, 21 Hastings Const. L.Q. 15, 17
(1993) (detailing history of the right to petition from 1215 through colonial times, the
constitutional convention, and today). During our colonial period, the right to petition
was widely used. The importance of this right was fundamental - it guaranteed not
merely expression but the preservation of democracy. "The very idea of government,
republican in form, implies a right on the part of its citizens to meet peaceably for
consultation in respect to public affairs and to petition for a redress of grievances."
United States v. Cruikshank,
*19
Supreme Court has extended Noerr immunity to actions before administrative agencies
and the courts, Cal. Motor Transp.,
The Supreme Court has yet to speak definitively on extending petitioning
immunity to settlement agreements with sovereign states. Relying on a statement in
Broadcast Music, Inc. v. Columbia Broadcasting Systems Inc., plaintiffs claim the
Supreme Court refused to extend immunity to settlement agreements when it stated that a
"consent judgment, even one entered at the behest of the Antitrust Division, does not
immunize the defendant from liability for actions, including those contemplated by the
decree, that violates the rights of nonparties."
*20
of a consent decree. The Supreme Court ruled that the consent decree did not immunize
the anticompetitive actions taken by private parties. For the above quoted language,
Broadcast Music relied upon Sam Fox Publishing Co. v. United States,
689 (1961), which did not involve Noerr-Pennington immunity. Sam Fox addressed
whether a non-participant is bound by the outcome of government antitrust litigation. Id.
Neither Broadcast Music nor Sam Fox mentioned Noerr-Pennington immunity, and
neither is applicable to the facts here.
Plaintiffs claim a motivating purpose behind the Multistate
Settlement Agreement
was to create a cartel guaranteeing tobacco companies supracompetitive profits. Br. of
Appellants at 49. Similarly, plaintiffs claim the States were motivated by a desire to
share in these revenues. But the parties' motives are generally irrelevant and carry no
legal significance. See Noerr,
Cottrell,
Having found the defendants immune under Noerr-Pennington, our analysis could end here. But the District Court found Parker immunity, so we will address it as well.
Antitrust laws do not bar anticompetitive restraints that sovereign states impose
"as an act of government." Parker v. Brown,
*21
The Parker doctrine relies heavily on the clarity of the State's goals and actions.
"[S]tates must accept political responsibility for the actions they intend to undertake."
FTC v. Ticor Title Ins. Co.,
Id. Because it is grounded in federalism and respect for state sovereignty, this interest in
protecting the acts of the sovereign state, even if anticompetitive, outweighs the
importance of a freely competitive marketplace, especially in the absence of contrary
congressional intent.
Without clear congressional intent to preempt, federal laws should not invalidate
state programs. "In a dual system of government in which, under the Constitution, the
states are sovereign, save only as Congress may constitutionally subtract from their
authority, an unexpressed purpose to nullify a state's control over its officers and agents
is not lightly to be attributed to Congress." Parker v. Brown,
*22
prohibit anticompetitive actions by the States in their governmental capacities as
sovereign regulators." City of Columbia v. Omni Outdoor Adver.,
*23
When it is uncertain whether an act should be treated as state action for the
purposes of Parker immunity, we apply the test set forth in California Retail Liquor
Dealers Association v. Midcal Aluminum, Inc.,
The Supreme Court has recognized state legislative and judicial action as
sovereign under Parker. But "[c]loser analysis is required" when the action is less
directly that of the legislature or judiciary. Hoover v. Ronwin,
*24 constitute state action that avoids Midcal analysis. Furthermore, in this case, we must determine whether the antitrust injuries were more attributable to private parties than to government action, as was the case in Midcal.
- Direct Application of Parker
An argument can be made that the Multistate Settlement Agreement, and any of its anticompetitive effects, were the direct result of state government action. For each signatory state, there was active involvement by high ranking executive officials and the agreement was subject to state court approval. The Multistate Settlement Agreement was negotiated by Attorneys General from each state to settle existing and contemplated lawsuits. The Multistate Settlement Agreement required that, each Settling State that is a party to a lawsuit . . . and each
Participating Manufacturer will: (A) tender this agreement to the Court in such Settling State for its approval; and (B) tender to the Court in such Settling state for entry of a consent decree conforming to the model consent decree attached hereto as Exhibit L.
MSA
XIII(b)(1); see also PTI,
*25
tobacco companies. Additionally, each branch of state government had a role in the
execution or operation of the Multistate Settlement Agreement. Under this analysis, one
could find direct state action foreclosing the application of Midcal. Under a different view, we focus not on the negotiation and consummation of the
Multistate Settlement Agreement, but on its actual operation and resulting effects, since
that is the true cause of the anticompetitive effects. This is how the Supreme Court
analyzed the behavior in Midcal.
In Midcal, the price setting structure that resulted in antitrust injury would not
have existed but for the state regulation. Only because of state legislative enactments did
California wine producers hold power over the wholesalers to engage in resale price
maintenance. Midcal,
*26
discretionary authority."
*27 by hybrid acts involving private parties in the unique setting of a joint settlement, we believe this form of alleged anticompetitive restraint requires the Midcal analysis. 2. Midcal
To qualify as state action under the Midcal test, "the challenged restraint must be
one 'clearly articulated and affirmatively expressed as state policy.'"
*28
dismissed under the consent agreements. The state legislatures also demonstrated their
approval in most of the States by passing implementing legislation. See Cal. Aviation
Inc.,
*29 with this characterization, it is clear the Multistate Settlement Agreement empowers the tobacco companies to make anticompetitive decisions with no regulatory oversight by the States. Specifically, the defendants are free to fix and raise prices, allegedly without fear of competition. The question then is whether the Multistate Settlement Agreement, with all its duties and responsibilities, creates sufficient state supervision even though the pricing decisions are unregulated. The States actively and continually monitor the implementation of portions of the Multistate Settlement Agreement. See MSA VII-VIII. After requiring a state court consent decree, the Multistate Settlement Agreement also mandates state courts to maintain continuing jurisdiction over enforcement of disputes between the States and the tobacco companies. See MSA VII(a). Under the Multistate Settlement Agreement, the state courts may order compliance in the form of an Enforcement Order. See MSA VII(c)(3). If a State Attorney General believes a manufacturer has failed to comply with an Enforcement Order, it may seek an order for civil contempt or monetary sanction to force compliance. See MSA VII(c)(4). Furthermore, for a period of seven years after settlement, the Attorney General of a Settling State may inspect all nonprivileged records of the tobacco companies, and will have access to interview directors, officers and employees upon reasonable belief of a violation of the Multistate Settlement Agreement. See MSA VII(g). The Multistate Settlement Agreement also establishes a million fund to assist the States in enforcing the Multistate Settlement Agreement. See MSA VIII(c). This fund is to be used to supplement the States' (1) enforcement and implementation of the terms of [the Multistate Settlement Agreement] and consent decrees, and (2) investigation and litigation of potential violations of laws with respect to Tobacco Products. Id. This includes prosecution of non-signatories for those underlying "torts" which initially
*30
led the States to sue the major tobacco companies.
The largest responsibilities for the tobacco companies are financial. The
Multistate Settlement Agreement details how and when the payments will be made to the
settling states each year. See MSA
IX. In addition, there is a limited "most-favored nation" provision. In the event a State settles with a nonsignatory
tobacco company (NPM) on terms more favorable than the Multistate Settlement
Agreement (a lower payment-per-pack amount), then all signatories will be entitled to a
revision of the Multistate Settlement Agreement to at least match the new agreement.
See MSA
XVIII(b)(2). There are also significant ongoing restrictions placed on the
tobacco manufacturers. They are prohibited from taking "any action, directly or
indirectly, to target Youth within any Settling State in the advertising, promotion, or
marketing of Tobacco Products," MSA III(a); they also agreed to refrain from using
"any cartoon in the advertising, promoting, packaging or labeling of Tobacco products."
MSA III(b).
Despite these factors, we are not convinced that the States satisfy Midcal's "active
supervision" prong. This is because the States' supervision does not reach the parts of
the Multistate Settlement Agreement that are the source of the antitrust injury. It is the
conduct that violates the antitrust laws that states must "actively supervise" in order for
Parker immunity to attach.
As we recognized in Norman's on the Waterfront, Inc. v. Wheatley, "an arrangement sponsored by the state is not necessarily state action for the purposes of the
antitrust laws."
*31
pricing by the regulated parties. Wheately,
Significantly, in Midcal, the State of California enacted a pricing system for the
wine industry. Because the State did not exercise direct control over the resulting prices
set by the private actors, and did not review the reasonableness of the prices, the
Supreme Court found insufficient "active supervision" to qualify as state action. Midcal,
*32
held that where a state statute authorized the creation of local tobacco boards to regulate
tobacco sales at auctions, and where the states did not continue to supervise the decisions
of these boards, the board's actions were not protected by Parker immunity. This
principle has also been applied in state granted monopoly cases. In Gas Light Co. of
Columbus v. Georgia Power Co.,
*33 happened. As noted, the Majors have raised their prices sharply and uniformly since the implementation of the Multistate Settlement Agreement Ā according to plaintiffs, by 50\% since 1997. See Complaint at . These price increases have not been monitored or regulated by the States. The Multistate Settlement Agreement imposes no restrictions on pricing or provisions to temper the effects of the output cartel. Under this set of facts, there is insufficient evidence of active supervision of the allegedly anticompetitive restraints to satisfy this prong of Midcal. Although the Multistate Settlement Agreement is the product of a "clearly articulated" state policy, because the States do not "actively supervise" the anticompetitive restraints, the participants are not entitled to Parker immunity.
*34
The question of Parker immunity's applicability is a difficult one. As noted, we hold we must apply the Midcal test. Although the States satisfy Midcal's "clear articulation" prong, they fail the second prong requiring them to actively supervise the anticompetitive restraints causing injury. Because private participants in state action enjoy Parker immunity only to the extent the States enjoy immunity, the defendants are not shielded by Parker. Therefore, consistent with the Supreme Court's treatment of hybrid restraints, we hold defendants are not immune under the Parker immunity doctrine.
IV.
Constitutional Claims
In its brief, and again at oral argument, plaintiffs asked us to find the Multistate
Settlement Agreement unconstitutional under the Commerce Clause or the Compact
Clause of the United States Constitution. But plaintiffs did not allege constitutional
violations in their amended complaint, nor did the District Court address them.
Therefore, these claims will not be addressed on appeal. Mahone v. Addicks Utility
Dist.,
*35
the court" in the absence of exceptional circumstances. General Eng'g Corp. v. Virgin
Islands Water and Power Auth. Caribbean Energy Co., Inc.,
Conclusion The Multistate Settlement Agreement creates novel issues because of the uniqueness of the instrument involving forty-six states and over of an industry. Although plaintiffs have properly pleaded an antitrust injury, the right to petition the government is paramount. Therefore, we hold defendants immune from antitrust liability under the Noerr-Pennington doctrine. But we find no immunity under the Parker doctrine. We will not address the constitutional issues. We will affirm the judgment of the District Court.
*36
TO THE CLERK:
Please file the foregoing opinion. /s/ Anthony J. Scirica Circuit Judge
